{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0005130,73,MONDO:0005130,138,-1]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0005130","source":"MONDO:0005130|celiac disease","targets":["NCT02475369|Pancreatic Enzyme Supplementation for Celiac Disease|TERMINATED|PHASE4|INTERVENTIONAL","NCT02806206|Prucalopride Prior to Small Bowel Capsule Endoscopy|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03351972|Differences in Preparation for Small Bowel Capsule Endoscopy|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03866538|Budesonide in Patients With Immune Mediated Enteropathies|TERMINATED|PHASE4|INTERVENTIONAL","NCT04160767|Celiac Disease and Vitamin Status: Evaluation of the Effect of Supplementation With a Probiotic (VIVOMIXX®) in a Cohoort of Celiac Patients|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04788797|AN-PEP on Gluten Exposure in Celiacs|COMPLETED|PHASE4|INTERVENTIONAL","NCT05114278|Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL)|NOT_YET_RECRUITING|PHASE4|INTERVENTIONAL","NCT00623025|Creon in HIV Patients With Steatorrhea|TERMINATED|PHASE3|INTERVENTIONAL","NCT00662675|A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency|COMPLETED|PHASE3|INTERVENTIONAL","NCT01045837|Effect of Addition of Short Course of Prednisolone to Gluten Free Diet in Naive Celiac Disease Patients|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT01100099|HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT01338324|Protocol for Correlating Enteropathic Severity and Small Intestinal CYP3A4 Activity in Patients With Celiac Disease|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT03569007|Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms|TERMINATED|PHASE3|INTERVENTIONAL","NCT00217204|An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption|COMPLETED|PHASE2|INTERVENTIONAL","NCT00362856|Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects|COMPLETED|PHASE2|INTERVENTIONAL","NCT00492960|Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease|COMPLETED|PHASE2|INTERVENTIONAL","NCT00540657|A Phase II Study of CCX282-B in Patients With Celiac Disease|COMPLETED|PHASE2|INTERVENTIONAL","NCT00620451|Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease|COMPLETED|PHASE2|INTERVENTIONAL","NCT00671138|Inoculating Celiac Disease Patients With the Human Hookworm Necator Americanus: Evaluating Immunity and Gluten-sensitivity|COMPLETED|PHASE2|INTERVENTIONAL","NCT00810654|Effect of Aspergillus Niger Prolyl Endoprotease (AN-PEP) Enzyme on the Effects of Gluten Ingestion in Patients With Coeliac Disease|COMPLETED|PHASE1/PHASE2|INTERVENTIONAL","NCT00889473|Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease|COMPLETED|PHASE2|INTERVENTIONAL","NCT00959114|Safety and Efficacy of ALV003 for the Treatment of Celiac Disease|COMPLETED|PHASE2|INTERVENTIONAL","NCT00962182|Study of Enzyme Supplements to Treat Celiac Disease|COMPLETED|PHASE1/PHASE2|INTERVENTIONAL","NCT01184378|Tolerance and Digestibility of a New Formula in Healthy Infants|COMPLETED|PHASE2|INTERVENTIONAL","NCT01255696|Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease|COMPLETED|PHASE2|INTERVENTIONAL","NCT01396213|A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease|COMPLETED|PHASE2|INTERVENTIONAL","NCT01661933|Desensitising Celiac Disease Patients With the Human Hookworm|COMPLETED|PHASE1/PHASE2|INTERVENTIONAL","NCT01917630|Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients|UNKNOWN|PHASE2|INTERVENTIONAL","NCT01990885|Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients.|COMPLETED|PHASE1/PHASE2|INTERVENTIONAL","NCT02220166|Safety of Prolonged Administration of Triticum Monococcum in Celiac Disease|COMPLETED|PHASE2|INTERVENTIONAL","NCT02244047|Cytokine Profile in Children With Celiac Disease|COMPLETED|PHASE1/PHASE2|INTERVENTIONAL","NCT02472119|Wheat Flour Treatment With Microbial Transglutaminase and Lysine Ethyl Ester: New Frontiers in Celiac Disease Treatment.|UNKNOWN|PHASE2|INTERVENTIONAL","NCT02637141|A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease|COMPLETED|PHASE2|INTERVENTIONAL","NCT02929316|Vedolizumab Induction May Prevent Celiac Enteritis|TERMINATED|PHASE2|INTERVENTIONAL","NCT03271138|Bifidobacterium Infantis NLS Super Strain for Celiac Disease Patients on a Gluten-free Diet With Persistent Gastrointestinal Symptoms|COMPLETED|PHASE2|INTERVENTIONAL","NCT03585478|Latiglutenase as a Treatment for Celiac Disease|COMPLETED|PHASE2|INTERVENTIONAL","NCT03644069|A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)|UNKNOWN|PHASE2|INTERVENTIONAL","NCT03707730|A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease|COMPLETED|PHASE2|INTERVENTIONAL","NCT03738475|Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease|COMPLETED|PHASE2|INTERVENTIONAL","NCT04243551|Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients|TERMINATED|PHASE2|INTERVENTIONAL","NCT04424927|PRV-015 in Gluten-free Diet Non-responsive Celiac Disease|COMPLETED|PHASE2|INTERVENTIONAL","NCT04530123|Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet|COMPLETED|PHASE2|INTERVENTIONAL","NCT04806737|Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease|COMPLETED|PHASE1/PHASE2|INTERVENTIONAL","NCT04839575|Study of Latiglutenase in T1D/CD Patients|TERMINATED|PHASE2|INTERVENTIONAL","NCT05353985|A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet|COMPLETED|PHASE2|INTERVENTIONAL","NCT05574010|A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)|TERMINATED|PHASE1/PHASE2|INTERVENTIONAL","NCT05636293|Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission|RECRUITING|PHASE2|INTERVENTIONAL","NCT05646823|Probiotic Blend for Celiac Disease|UNKNOWN|PHASE2|INTERVENTIONAL","NCT05660109|A Study to Assess the Safety of TPM502 in Adults With Celiac Disease|COMPLETED|PHASE2|INTERVENTIONAL","NCT06001177|A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease|COMPLETED|PHASE2|INTERVENTIONAL","NCT06557772|A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease|ACTIVE_NOT_RECRUITING|PHASE2|INTERVENTIONAL","NCT06807463|A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease|RECRUITING|PHASE2|INTERVENTIONAL","NCT06982963|Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease|RECRUITING|PHASE2|INTERVENTIONAL","NCT07239336|Study of DONQ52 in Active Celiac Disease|RECRUITING|PHASE2|INTERVENTIONAL","NCT07298343|Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease|ACTIVE_NOT_RECRUITING|PHASE2|INTERVENTIONAL","NCT07335523|Management of Steatorrhea in Children and Young Adults With Alagille Syndrome After Liver Transplantation|NOT_YET_RECRUITING|PHASE2|INTERVENTIONAL","NCT00386165|Safety Study of Larazotide Acetate to Treat Celiac Disease.|COMPLETED|PHASE1|INTERVENTIONAL","NCT00626184|A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease|COMPLETED|PHASE1|INTERVENTIONAL","NCT00669825|Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal|COMPLETED|PHASE1|INTERVENTIONAL","NCT00676702|A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)|COMPLETED|PHASE1|INTERVENTIONAL","NCT00879749|Safety Study of Nexvax2 in Subjects With Coeliac Disease|COMPLETED|PHASE1|INTERVENTIONAL","NCT01642862|Study for Identifying Optimal Simvastatin Formulation for Uniform Time to Maximum Plasma Concentration|TERMINATED|PHASE1|INTERVENTIONAL","NCT01765647|Oral AGY for Celiac Disease|COMPLETED|PHASE1|INTERVENTIONAL","NCT01893775|Antibody Treatment for Advanced Celiac Disease|COMPLETED|PHASE1|INTERVENTIONAL","NCT02344758|Gluten-free Diet Monitoring in Urine|COMPLETED|EARLY_PHASE1|INTERVENTIONAL","NCT02528799|Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease|COMPLETED|PHASE1|INTERVENTIONAL","NCT02679014|A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac Disease|COMPLETED|PHASE1|INTERVENTIONAL","NCT02754609|Hookworm Therapy for Coeliac Disease|COMPLETED|PHASE1|INTERVENTIONAL","NCT03011931|Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]|COMPLETED|EARLY_PHASE1|INTERVENTIONAL","NCT03486990|Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease|COMPLETED|PHASE1|INTERVENTIONAL","NCT03543540|Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease|COMPLETED|PHASE1|INTERVENTIONAL","NCT04054544|Gluten Challenge Study in Celiac Disease Participants (MK-0000-402)|COMPLETED|EARLY_PHASE1|INTERVENTIONAL","NCT04248855|Assessment of KAN-101 in Celiac Disease (ACeD)|COMPLETED|PHASE1|INTERVENTIONAL","NCT04524221|PTG-100 for Patients With Celiac Disease|COMPLETED|PHASE1|INTERVENTIONAL","NCT04593251|Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis|COMPLETED|PHASE1|INTERVENTIONAL","NCT04604795|Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole|COMPLETED|PHASE1|INTERVENTIONAL","NCT04704843|A Study of Guselkumab in Adult Participants With Celiac Disease|WITHDRAWN|PHASE1|INTERVENTIONAL","NCT05425446|Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients|COMPLETED|PHASE1|INTERVENTIONAL","NCT05555446|Bovine Colostrum to Prevent Absorption of Gluten|SUSPENDED|EARLY_PHASE1|INTERVENTIONAL","NCT06310291|VTP-1000 in Adults With Celiac Disease|RECRUITING|EARLY_PHASE1|INTERVENTIONAL","NCT06324604|Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients|RECRUITING|PHASE1|INTERVENTIONAL","NCT07063823|A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease|RECRUITING|PHASE1|INTERVENTIONAL","NCT07377565|A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease|NOT_YET_RECRUITING|PHASE1|INTERVENTIONAL","NCT00006492|Gluten-Free Diet in Patients With Gluten Sensitivity and Cerebellar Ataxia|COMPLETED|nan|OBSERVATIONAL","NCT00138879|Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients|COMPLETED|nan|OBSERVATIONAL","NCT00175760|Can a Very High Result From a Screening Test for Celiac Disease be Used to Diagnose Celiac Disease?|COMPLETED|nan|OBSERVATIONAL","NCT00250146|Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease|TERMINATED|nan|INTERVENTIONAL","NCT00555737|Performance Evaluation of Capsule Endoscopy in the Diagnosis of Gluten Sensitive Enteropathy (MA-23)|COMPLETED|nan|OBSERVATIONAL","NCT00617838|Celiac Disease Prevention|UNKNOWN|nan|INTERVENTIONAL","NCT00628823|Treatment of Mild Enteropathy Celiac Disease|COMPLETED|nan|INTERVENTIONAL","NCT00639444|Risk of Celiac Disease and Age at Gluten Introduction|COMPLETED|nan|INTERVENTIONAL","NCT00677495|Gluten-free Diet in Gluten-genetically Predisposed Subjects|COMPLETED|nan|INTERVENTIONAL","NCT00739128|Response to Hepatitis B Vaccine in Celiac Disease Patients|TERMINATED|nan|INTERVENTIONAL","NCT00782366|Predictive Genetic Risk Assessment Trial|COMPLETED|nan|OBSERVATIONAL","NCT00819819|Infant Nutrition and Risk of Celiac Disease|TERMINATED|nan|INTERVENTIONAL","NCT00854490|Follow-up Study of Small-intestinal Mucosal Injuries in Chronic Non-steroidal Anti-inflammatory Drugs (NSAIDs)-Users|UNKNOWN|nan|OBSERVATIONAL","NCT00859391|Effects of Gluten Digestion With ALV003|COMPLETED|nan|OBSERVATIONAL","NCT00931892|Serum Markers in Gluten Challenge|COMPLETED|nan|INTERVENTIONAL","NCT01116505|Treatment of Screen-detected Celiac Disease|COMPLETED|nan|INTERVENTIONAL","NCT01129908|Saliva Composition and Oral Hygiene in Children With Celiac Disease Before and After the Change in Diet|COMPLETED|nan|OBSERVATIONAL"]}]}